The First Affiliated Hospital of Guangdong Pharmaceutical University
23
1
1
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
4.3%
1 terminated/withdrawn out of 23 trials
80.0%
-6.5% vs industry average
39%
9 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (23)
Efficacy of Diacylglycerol Oil on Metabolic Risk Factors in Prediabetes
Role: lead
Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction
Role: collaborator
Washed Microbiota Transplantation for Malnutrition After Nonphysiological Reconstruction of the Upper Gastrointestinal Tract
Role: collaborator
Study of Efficacy, Weight Control, and Safety in Newly-diagnosed Type 2 Diabetes With Different Antidiabetic Therapy
Role: collaborator
Surface EMGdi Evaluate the Efficacy of Pulmonary Rehabilitation in Patients With COPD: a Multi Center Prospective Study
Role: collaborator
Dynamic Follow-up of Symptoms Based on Patient-reported Outcomes in Immunotherapy for Esophageal Cancer: a Prospective Multicentre Cohort Study (SPRING)
Role: collaborator
Methodology and Clinical Value of RIT in Intestinal Obstructive Diseases Mediated by Colonic TET
Role: collaborator
Clinical Observation for the Therapeutic Effect of mNGF on Cognitive Decline in Cerebral Small Vessel Disease
Role: collaborator
Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Role: collaborator
Compare S-1 for 6 Months to 1 Year as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Staged II , IIIA or IIIB.
Role: collaborator
Extensive Intraoperative Peritoneal Lavage After Curative Gastrectomy for Locally Advanced Gastric Cancer (SEIPLUS)
Role: collaborator
Long-term MOno-Antiplatelet Drug Strategy After PerCutanEous CoronAry InterveNtion
Role: collaborator
CAR T and PD-1 Knockout Engineered T Cells for Esophageal Cancer
Role: lead
Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC
Role: lead
Therapeutic Vaccine Plus PD-1 Knockout in Prostate Cancer Treatment
Role: lead
Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC
Role: collaborator
Therapeutic Effects of Compound Zhenzhu Tiaozhi Capsules in NAFLD
Role: lead
A Study of Anti-CD19 CAR-T Cell Immunotherapy for Refractory /Relapsed B Cell Malignancies
Role: collaborator
Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal Carcinoma
Role: collaborator
Study on the Anti-HPA Antibodies Caused Neonatal Alloimmune Thrombocytopenia in Chinese Pregnant Women
Role: collaborator